RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value: $3.298B (100.0% shares, 0.0% debt)

Holdings (34)

— SYNTHORX INC 20.6%
Value $680M Shares 9,724,598 Share Price $69.89 Est. Cost/Share $17.38 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 17.7%
Value $582M Shares 4,185,342 Share Price $139.12 Est. Cost/Share $19.49 Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 6.9%
Value $228M Shares 4,858,260 Share Price $46.93 Est. Cost/Share $8.41 Unrealized @ Report Date —
ARVN ARVINAS INC 4.6%
Value $151M Shares 3,672,872 Share Price $41.09 * Est. Cost/Share $23.47 Unrealized @ Report Date +24.7%
— CHEMOCENTRYX INC 3.8%
Value $127M Shares 3,199,389 Share Price $39.55 Est. Cost/Share $39.55 Unrealized @ Report Date —
RYTM RHYTHM PHARMACEUTICALS INC 3.8%
Value $124M Shares 5,422,312 Share Price $22.96 * Est. Cost/Share $24.09 Unrealized @ Report Date -7.8%
— EIDOS THERAPEUTICS INC 3.8%
Value $124M Shares 2,162,671 Share Price $57.39 Est. Cost/Share $20.34 Unrealized @ Report Date —
— ZOGENIX INC 3.6%
Value $118M Shares 2,260,751 Share Price $52.13 Est. Cost/Share $37.11 Unrealized @ Report Date —
PHAT PHATHOM PHARMACEUTICALS INC 3.4%
Value $114M Shares 3,646,808 Share Price $31.14 * Est. Cost/Share $25.13 Unrealized @ Report Date 0.0%
TGTX TG THERAPEUTICS INC 3.3%
Value $110M Shares 9,880,323 Share Price $11.10 * Est. Cost/Share $10.91 Unrealized @ Report Date -30.3%
— SATSUMA PHARMACEUTICALS INC 2.8%
Value $92.14M Shares 4,681,858 Share Price $19.68 Est. Cost/Share $15.01 Unrealized @ Report Date —
— ORCHARD THERAPEUTICS PLC 2.7%
Value $87.86M Shares 6,389,901 Share Price $13.75 Est. Cost/Share $15.39 Unrealized @ Report Date —
— 89BIO INC 2.5%
Value $83.11M Shares 3,161,214 Share Price $26.29 Est. Cost/Share $26.29 Unrealized @ Report Date —
— FORTY SEVEN INC 2.3%
Value $76.11M Shares 1,933,250 Share Price $39.37 Est. Cost/Share $39.37 Unrealized @ Report Date —
WVE WAVE LIFE SCIENCES LTD 1.9%
Value $62.32M Shares 7,775,207 Share Price $8.01 * Est. Cost/Share $17.26 Unrealized @ Report Date +42.1%
— RETROPHIN INC 1.8%
Value $60.38M Shares 4,252,453 Share Price $14.20 Est. Cost/Share $11.75 Unrealized @ Report Date —
— AUDENTES THERAPEUTICS INC 1.6%
Value $54M Shares 902,383 Share Price $59.84 Est. Cost/Share $59.84 Unrealized @ Report Date —
— PREVAIL THERAPEUTICS INC 1.6%
Value $53.25M Shares 3,363,605 Share Price $15.83 Est. Cost/Share $13.03 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS INC 1.4%
Value $47.05M Shares 1,875,209 Share Price $25.09 * Est. Cost/Share $29.55 Unrealized @ Report Date -35.6%
ARDX ARDELYX INC 1.2%
Value $40.22M Shares 5,358,863 Share Price $7.50 * Est. Cost/Share $6.08 Unrealized @ Report Date 0.0%
AXSM AXSOME THERAPEUTICS INC 1.2%
Value $38.02M Shares 367,816 Share Price $103.36 * Est. Cost/Share $9.29 Unrealized @ Report Date +335.0%
— IGM BIOSCIENCES INC 1.1%
Value $37.5M Shares 982,723 Share Price $38.16 Est. Cost/Share $28.47 Unrealized @ Report Date —
STOK STOKE THERAPEUTICS INC 1.0%
Value $31.72M Shares 1,119,963 Share Price $28.32 * Est. Cost/Share $26.85 Unrealized @ Report Date -6.3%
RLMD RELMADA THERAPEUTICS INC 0.9%
Value $29.7M Shares 761,666 Share Price $39.00 * Est. Cost/Share $28.22 Unrealized @ Report Date 0.0%
— MOMENTA PHARMACEUTICALS INC 0.9%
Value $28.53M Shares 1,445,801 Share Price $19.73 Est. Cost/Share $19.73 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 0.6%
Value $20.34M Shares 4,571,164 Share Price $4.45 Est. Cost/Share $8.67 Unrealized @ Report Date —
— SCPHARMACEUTICALS INC 0.6%
Value $18.38M Shares 3,247,005 Share Price $5.66 Est. Cost/Share $11.02 Unrealized @ Report Date —
ALEC ALECTOR INC 0.5%
Value $17.23M Shares 1,000,000 Share Price $17.23 Est. Cost/Share $18.92 Unrealized @ Report Date -10.1%
— KALA PHARMACEUTICALS INC 0.5%
Value $16.74M Shares 4,537,478 Share Price $3.69 Est. Cost/Share $13.25 Unrealized @ Report Date —
GRTX GALERA THERAPEUTICS INC 0.4%
Value $13.87M Shares 1,054,178 Share Price $13.16 * Est. Cost/Share $12.19 Unrealized @ Report Date 0.0%
— DYNAVAX TECHNOLOGIES CORP 0.4%
Value $13.53M Shares 2,365,912 Share Price $5.72 Est. Cost/Share $3.57 Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 0.3%
Value $10.25M Shares 429,399 Share Price $23.88 Est. Cost/Share $26.82 Unrealized @ Report Date —
— ESSA PHARMA INC 0.2%
Value $5.5M Shares 1,000,000 Share Price $5.50 Est. Cost/Share $3.37 Unrealized @ Report Date —
— X4 PHARMACEUTICALS INC 0.1%
Value $2.892M Shares 270,292 Share Price $10.70 Est. Cost/Share $15.00 Unrealized @ Report Date —